nodes	percent_of_prediction	percent_of_DWPC	metapath
Metformin—SLC22A3—Irinotecan—colon cancer	0.111	0.534	CbGbCtD
Metformin—SLC22A3—Vincristine—colon cancer	0.0969	0.466	CbGbCtD
Metformin—ND4—digestive system—colon cancer	0.00134	0.0033	CbGeAlD
Metformin—NDUFB4—renal system—colon cancer	0.00133	0.00329	CbGeAlD
Metformin—NDUFA2—lymphoid tissue—colon cancer	0.00133	0.00327	CbGeAlD
Metformin—NDUFAB1—renal system—colon cancer	0.00132	0.00327	CbGeAlD
Metformin—NDUFB9—renal system—colon cancer	0.00131	0.00325	CbGeAlD
Metformin—NDUFA8—renal system—colon cancer	0.00131	0.00325	CbGeAlD
Metformin—NDUFAF3—liver—colon cancer	0.00131	0.00324	CbGeAlD
Metformin—NDUFA4—renal system—colon cancer	0.00131	0.00323	CbGeAlD
Metformin—NDUFV1—renal system—colon cancer	0.0013	0.00321	CbGeAlD
Metformin—NDUFB11—renal system—colon cancer	0.0013	0.00321	CbGeAlD
Metformin—NDUFA4L2—vagina—colon cancer	0.0013	0.0032	CbGeAlD
Metformin—NDUFB8—renal system—colon cancer	0.00129	0.00319	CbGeAlD
Metformin—NDUFS5—renal system—colon cancer	0.00129	0.00319	CbGeAlD
Metformin—ND3—bone marrow—colon cancer	0.00127	0.00314	CbGeAlD
Metformin—ND4L—bone marrow—colon cancer	0.00127	0.00314	CbGeAlD
Metformin—ND2—bone marrow—colon cancer	0.00127	0.00314	CbGeAlD
Metformin—ND5—bone marrow—colon cancer	0.00127	0.00314	CbGeAlD
Metformin—NDUFA10—lymphoid tissue—colon cancer	0.00126	0.00312	CbGeAlD
Metformin—NDUFA10—digestive system—colon cancer	0.00125	0.00308	CbGeAlD
Metformin—NDUFB2—lymphoid tissue—colon cancer	0.00124	0.00307	CbGeAlD
Metformin—ND4—bone marrow—colon cancer	0.00123	0.00304	CbGeAlD
Metformin—NDUFB2—digestive system—colon cancer	0.00123	0.00303	CbGeAlD
Metformin—ND6—lymphoid tissue—colon cancer	0.00122	0.00302	CbGeAlD
Metformin—NDUFS7—renal system—colon cancer	0.00121	0.00299	CbGeAlD
Metformin—ND6—digestive system—colon cancer	0.00121	0.00298	CbGeAlD
Metformin—NDUFA2—bone marrow—colon cancer	0.00121	0.00298	CbGeAlD
Metformin—NDUFA5—lymphoid tissue—colon cancer	0.00118	0.00292	CbGeAlD
Metformin—NDUFA9—liver—colon cancer	0.00118	0.00291	CbGeAlD
Metformin—NDUFA13—liver—colon cancer	0.00118	0.00291	CbGeAlD
Metformin—NDUFA5—digestive system—colon cancer	0.00117	0.00289	CbGeAlD
Metformin—NDUFS1—lymphoid tissue—colon cancer	0.00117	0.00288	CbGeAlD
Metformin—NDUFA1—liver—colon cancer	0.00116	0.00286	CbGeAlD
Metformin—NDUFB10—lymphoid tissue—colon cancer	0.00116	0.00286	CbGeAlD
Metformin—NDUFA2—vagina—colon cancer	0.00116	0.00285	CbGeAlD
Metformin—NDUFS1—digestive system—colon cancer	0.00115	0.00285	CbGeAlD
Metformin—NDUFA10—bone marrow—colon cancer	0.00115	0.00284	CbGeAlD
Metformin—NDUFA12—lymphoid tissue—colon cancer	0.00115	0.00284	CbGeAlD
Metformin—NDUFB10—digestive system—colon cancer	0.00114	0.00283	CbGeAlD
Metformin—NDUFB1—lymphoid tissue—colon cancer	0.00114	0.00282	CbGeAlD
Metformin—NDUFC1—bone marrow—colon cancer	0.00114	0.00282	CbGeAlD
Metformin—NDUFB7—digestive system—colon cancer	0.00114	0.00281	CbGeAlD
Metformin—NDUFB2—bone marrow—colon cancer	0.00113	0.00279	CbGeAlD
Metformin—NDUFB1—digestive system—colon cancer	0.00113	0.00279	CbGeAlD
Metformin—NDUFS8—digestive system—colon cancer	0.00113	0.00279	CbGeAlD
Metformin—NDUFA6—lymphoid tissue—colon cancer	0.00113	0.00278	CbGeAlD
Metformin—NDUFV2—liver—colon cancer	0.00112	0.00278	CbGeAlD
Metformin—NDUFC2—epithelium—colon cancer	0.00112	0.00278	CbGeAlD
Metformin—NDUFAF1—bone marrow—colon cancer	0.00112	0.00277	CbGeAlD
Metformin—NDUFS4—lymphoid tissue—colon cancer	0.00112	0.00276	CbGeAlD
Metformin—NDUFA6—digestive system—colon cancer	0.00111	0.00275	CbGeAlD
Metformin—NDUFB5—digestive system—colon cancer	0.00111	0.00275	CbGeAlD
Metformin—ND6—bone marrow—colon cancer	0.00111	0.00275	CbGeAlD
Metformin—PRKAB1—renal system—colon cancer	0.00111	0.00273	CbGeAlD
Metformin—NDUFS4—digestive system—colon cancer	0.00111	0.00273	CbGeAlD
Metformin—NDUFB4—lymphoid tissue—colon cancer	0.00111	0.00273	CbGeAlD
Metformin—NDUFB3—bone marrow—colon cancer	0.0011	0.00273	CbGeAlD
Metformin—NDUFAF2—bone marrow—colon cancer	0.0011	0.00273	CbGeAlD
Metformin—NDUFAB1—lymphoid tissue—colon cancer	0.0011	0.00271	CbGeAlD
Metformin—NDUFC1—vagina—colon cancer	0.00109	0.0027	CbGeAlD
Metformin—NDUFB4—digestive system—colon cancer	0.00109	0.0027	CbGeAlD
Metformin—NDUFB9—lymphoid tissue—colon cancer	0.00109	0.00269	CbGeAlD
Metformin—NDUFA8—lymphoid tissue—colon cancer	0.00109	0.00269	CbGeAlD
Metformin—NDUFAB1—digestive system—colon cancer	0.00108	0.00268	CbGeAlD
Metformin—NDUFA4—lymphoid tissue—colon cancer	0.00108	0.00268	CbGeAlD
Metformin—NDUFB2—vagina—colon cancer	0.00108	0.00268	CbGeAlD
Metformin—NDUFA7—lymph node—colon cancer	0.00108	0.00266	CbGeAlD
Metformin—NDUFA5—bone marrow—colon cancer	0.00108	0.00266	CbGeAlD
Metformin—NDUFB11—lymphoid tissue—colon cancer	0.00108	0.00266	CbGeAlD
Metformin—NDUFV1—lymphoid tissue—colon cancer	0.00108	0.00266	CbGeAlD
Metformin—NDUFB9—digestive system—colon cancer	0.00108	0.00266	CbGeAlD
Metformin—NDUFA8—digestive system—colon cancer	0.00108	0.00266	CbGeAlD
Metformin—NDUFAF1—vagina—colon cancer	0.00107	0.00265	CbGeAlD
Metformin—NDUFS5—lymphoid tissue—colon cancer	0.00107	0.00265	CbGeAlD
Metformin—NDUFB8—lymphoid tissue—colon cancer	0.00107	0.00265	CbGeAlD
Metformin—NDUFA4—digestive system—colon cancer	0.00107	0.00265	CbGeAlD
Metformin—NDUFAF4—bone marrow—colon cancer	0.00107	0.00264	CbGeAlD
Metformin—NDUFB6—bone marrow—colon cancer	0.00107	0.00264	CbGeAlD
Metformin—NDUFB11—digestive system—colon cancer	0.00107	0.00263	CbGeAlD
Metformin—NDUFV1—digestive system—colon cancer	0.00107	0.00263	CbGeAlD
Metformin—NDUFS1—bone marrow—colon cancer	0.00106	0.00262	CbGeAlD
Metformin—NDUFS5—digestive system—colon cancer	0.00106	0.00261	CbGeAlD
Metformin—NDUFB8—digestive system—colon cancer	0.00106	0.00261	CbGeAlD
Metformin—NDUFAF2—vagina—colon cancer	0.00106	0.00261	CbGeAlD
Metformin—NDUFB3—vagina—colon cancer	0.00106	0.00261	CbGeAlD
Metformin—NDUFB10—bone marrow—colon cancer	0.00105	0.0026	CbGeAlD
Metformin—NDUFA12—bone marrow—colon cancer	0.00105	0.00259	CbGeAlD
Metformin—NDUFB7—bone marrow—colon cancer	0.00105	0.00259	CbGeAlD
Metformin—NDUFC2—renal system—colon cancer	0.00104	0.00257	CbGeAlD
Metformin—NDUFS2—smooth muscle tissue—colon cancer	0.00104	0.00257	CbGeAlD
Metformin—NDUFB1—bone marrow—colon cancer	0.00104	0.00257	CbGeAlD
Metformin—NDUFS8—bone marrow—colon cancer	0.00104	0.00257	CbGeAlD
Metformin—NDUFA5—vagina—colon cancer	0.00103	0.00255	CbGeAlD
Metformin—NDUFA11—vagina—colon cancer	0.00103	0.00255	CbGeAlD
Metformin—ND3—liver—colon cancer	0.00103	0.00254	CbGeAlD
Metformin—ND4L—liver—colon cancer	0.00103	0.00254	CbGeAlD
Metformin—ND5—liver—colon cancer	0.00103	0.00254	CbGeAlD
Metformin—ND2—liver—colon cancer	0.00103	0.00254	CbGeAlD
Metformin—NDUFS3—smooth muscle tissue—colon cancer	0.00103	0.00254	CbGeAlD
Metformin—NDUFA6—bone marrow—colon cancer	0.00103	0.00253	CbGeAlD
Metformin—NDUFB5—bone marrow—colon cancer	0.00103	0.00253	CbGeAlD
Metformin—NDUFAF4—vagina—colon cancer	0.00103	0.00253	CbGeAlD
Metformin—NDUFB6—vagina—colon cancer	0.00103	0.00253	CbGeAlD
Metformin—NDUFS4—bone marrow—colon cancer	0.00102	0.00252	CbGeAlD
Metformin—NDUFB10—vagina—colon cancer	0.00101	0.0025	CbGeAlD
Metformin—NDUFB4—bone marrow—colon cancer	0.00101	0.00248	CbGeAlD
Metformin—NDUFA12—vagina—colon cancer	0.001	0.00248	CbGeAlD
Metformin—NDUFB7—vagina—colon cancer	0.001	0.00248	CbGeAlD
Metformin—NDUFS2—renal system—colon cancer	0.001	0.00247	CbGeAlD
Metformin—NDUFAB1—bone marrow—colon cancer	0.001	0.00247	CbGeAlD
Metformin—NDUFS8—vagina—colon cancer	0.000997	0.00246	CbGeAlD
Metformin—NDUFB1—vagina—colon cancer	0.000997	0.00246	CbGeAlD
Metformin—ND4—liver—colon cancer	0.000996	0.00246	CbGeAlD
Metformin—NDUFB9—bone marrow—colon cancer	0.000994	0.00245	CbGeAlD
Metformin—NDUFA8—bone marrow—colon cancer	0.000994	0.00245	CbGeAlD
Metformin—NDUFS7—digestive system—colon cancer	0.000992	0.00245	CbGeAlD
Metformin—NDUFS3—renal system—colon cancer	0.00099	0.00244	CbGeAlD
Metformin—NDUFA4—bone marrow—colon cancer	0.000988	0.00244	CbGeAlD
Metformin—Neutropenia—Vincristine—colon cancer	0.000984	0.0049	CcSEcCtD
Metformin—NDUFB5—vagina—colon cancer	0.000983	0.00243	CbGeAlD
Metformin—NDUFA6—vagina—colon cancer	0.000983	0.00243	CbGeAlD
Metformin—NDUFV1—bone marrow—colon cancer	0.000982	0.00242	CbGeAlD
Metformin—NDUFB11—bone marrow—colon cancer	0.000982	0.00242	CbGeAlD
Metformin—NDUFS4—vagina—colon cancer	0.000977	0.00241	CbGeAlD
Metformin—NDUFB8—bone marrow—colon cancer	0.000976	0.00241	CbGeAlD
Metformin—NDUFS5—bone marrow—colon cancer	0.000976	0.00241	CbGeAlD
Metformin—NDUFA2—liver—colon cancer	0.000975	0.00241	CbGeAlD
Metformin—NDUFB4—vagina—colon cancer	0.000964	0.00238	CbGeAlD
Metformin—Neutropenia—Irinotecan—colon cancer	0.000959	0.00477	CcSEcCtD
Metformin—NDUFAB1—vagina—colon cancer	0.000958	0.00237	CbGeAlD
Metformin—Angina pectoris—Fluorouracil—colon cancer	0.000956	0.00476	CcSEcCtD
Metformin—Upper respiratory tract infection—Irinotecan—colon cancer	0.000953	0.00474	CcSEcCtD
Metformin—NDUFA8—vagina—colon cancer	0.000952	0.00235	CbGeAlD
Metformin—NDUFB9—vagina—colon cancer	0.000952	0.00235	CbGeAlD
Metformin—NDUFA4—vagina—colon cancer	0.000946	0.00234	CbGeAlD
Metformin—NDUFV1—vagina—colon cancer	0.000941	0.00232	CbGeAlD
Metformin—NDUFB11—vagina—colon cancer	0.000941	0.00232	CbGeAlD
Metformin—NDUFS5—vagina—colon cancer	0.000935	0.00231	CbGeAlD
Metformin—NDUFB8—vagina—colon cancer	0.000935	0.00231	CbGeAlD
Metformin—NDUFA10—liver—colon cancer	0.000931	0.0023	CbGeAlD
Metformin—Ear pain—Capecitabine—colon cancer	0.00093	0.00463	CcSEcCtD
Metformin—NDUFC1—liver—colon cancer	0.000922	0.00228	CbGeAlD
Metformin—Neuropathy peripheral—Vincristine—colon cancer	0.00092	0.00458	CcSEcCtD
Metformin—NDUFS7—bone marrow—colon cancer	0.000915	0.00226	CbGeAlD
Metformin—NDUFB2—liver—colon cancer	0.000914	0.00226	CbGeAlD
Metformin—Upper respiratory tract infection—Fluorouracil—colon cancer	0.000912	0.00454	CcSEcCtD
Metformin—PRKAB1—digestive system—colon cancer	0.000908	0.00224	CbGeAlD
Metformin—NDUFAF1—liver—colon cancer	0.000907	0.00224	CbGeAlD
Metformin—ND6—liver—colon cancer	0.000899	0.00222	CbGeAlD
Metformin—NDUFB3—liver—colon cancer	0.000892	0.0022	CbGeAlD
Metformin—NDUFAF2—liver—colon cancer	0.000892	0.0022	CbGeAlD
Metformin—NDUFS7—vagina—colon cancer	0.000876	0.00216	CbGeAlD
Metformin—Infestation NOS—Fluorouracil—colon cancer	0.000875	0.00436	CcSEcCtD
Metformin—Infestation—Fluorouracil—colon cancer	0.000875	0.00436	CcSEcCtD
Metformin—NDUFA11—liver—colon cancer	0.000872	0.00215	CbGeAlD
Metformin—NDUFA5—liver—colon cancer	0.000872	0.00215	CbGeAlD
Metformin—NDUFC2—lymphoid tissue—colon cancer	0.000866	0.00214	CbGeAlD
Metformin—NDUFAF4—liver—colon cancer	0.000865	0.00214	CbGeAlD
Metformin—NDUFB6—liver—colon cancer	0.000865	0.00214	CbGeAlD
Metformin—NDUFV2—lymph node—colon cancer	0.000863	0.00213	CbGeAlD
Metformin—NDUFS1—liver—colon cancer	0.000859	0.00212	CbGeAlD
Metformin—Neuropathy peripheral—Fluorouracil—colon cancer	0.000858	0.00427	CcSEcCtD
Metformin—NDUFC2—digestive system—colon cancer	0.000855	0.00211	CbGeAlD
Metformin—ND1—smooth muscle tissue—colon cancer	0.000854	0.00211	CbGeAlD
Metformin—NDUFB10—liver—colon cancer	0.000853	0.00211	CbGeAlD
Metformin—NDUFA12—liver—colon cancer	0.000847	0.00209	CbGeAlD
Metformin—NDUFB7—liver—colon cancer	0.000847	0.00209	CbGeAlD
Metformin—NDUFS8—liver—colon cancer	0.000841	0.00208	CbGeAlD
Metformin—NDUFB1—liver—colon cancer	0.000841	0.00208	CbGeAlD
Metformin—NDUFA4L2—lymph node—colon cancer	0.000839	0.00207	CbGeAlD
Metformin—Hypoaesthesia—Vincristine—colon cancer	0.000838	0.00417	CcSEcCtD
Metformin—PRKAB1—bone marrow—colon cancer	0.000837	0.00207	CbGeAlD
Metformin—Bradycardia—Irinotecan—colon cancer	0.000835	0.00416	CcSEcCtD
Metformin—Renal impairment—Capecitabine—colon cancer	0.000834	0.00415	CcSEcCtD
Metformin—NDUFS2—lymphoid tissue—colon cancer	0.000832	0.00206	CbGeAlD
Metformin—NDUFB5—liver—colon cancer	0.000829	0.00205	CbGeAlD
Metformin—NDUFA6—liver—colon cancer	0.000829	0.00205	CbGeAlD
Metformin—Connective tissue disorder—Vincristine—colon cancer	0.000828	0.00412	CcSEcCtD
Metformin—NDUFS4—liver—colon cancer	0.000824	0.00203	CbGeAlD
Metformin—Rhinitis—Irinotecan—colon cancer	0.000823	0.0041	CcSEcCtD
Metformin—ND1—renal system—colon cancer	0.000822	0.00203	CbGeAlD
Metformin—NDUFS2—digestive system—colon cancer	0.000822	0.00203	CbGeAlD
Metformin—NDUFS3—lymphoid tissue—colon cancer	0.000822	0.00203	CbGeAlD
Metformin—NDUFB4—liver—colon cancer	0.000813	0.00201	CbGeAlD
Metformin—NDUFS3—digestive system—colon cancer	0.000812	0.00201	CbGeAlD
Metformin—Lethargy—Capecitabine—colon cancer	0.00081	0.00403	CcSEcCtD
Metformin—NDUFAB1—liver—colon cancer	0.000808	0.002	CbGeAlD
Metformin—Connective tissue disorder—Irinotecan—colon cancer	0.000806	0.00402	CcSEcCtD
Metformin—NDUFA8—liver—colon cancer	0.000803	0.00198	CbGeAlD
Metformin—NDUFB9—liver—colon cancer	0.000803	0.00198	CbGeAlD
Metformin—PRKAB1—vagina—colon cancer	0.000801	0.00198	CbGeAlD
Metformin—NDUFA4—liver—colon cancer	0.000798	0.00197	CbGeAlD
Metformin—Pain in extremity—Capecitabine—colon cancer	0.000794	0.00395	CcSEcCtD
Metformin—NDUFV1—liver—colon cancer	0.000794	0.00196	CbGeAlD
Metformin—NDUFB11—liver—colon cancer	0.000794	0.00196	CbGeAlD
Metformin—ND4L—lymph node—colon cancer	0.000789	0.00195	CbGeAlD
Metformin—ND2—lymph node—colon cancer	0.000789	0.00195	CbGeAlD
Metformin—ND3—lymph node—colon cancer	0.000789	0.00195	CbGeAlD
Metformin—ND5—lymph node—colon cancer	0.000789	0.00195	CbGeAlD
Metformin—NDUFB8—liver—colon cancer	0.000789	0.00195	CbGeAlD
Metformin—NDUFS5—liver—colon cancer	0.000789	0.00195	CbGeAlD
Metformin—NDUFC2—bone marrow—colon cancer	0.000788	0.00195	CbGeAlD
Metformin—Rhinitis—Fluorouracil—colon cancer	0.000788	0.00392	CcSEcCtD
Metformin—Cardiac disorder—Vincristine—colon cancer	0.000782	0.00389	CcSEcCtD
Metformin—Hypoaesthesia—Fluorouracil—colon cancer	0.000782	0.00389	CcSEcCtD
Metformin—Migraine—Capecitabine—colon cancer	0.000781	0.00389	CcSEcCtD
Metformin—Angiopathy—Vincristine—colon cancer	0.000764	0.00381	CcSEcCtD
Metformin—ND4—lymph node—colon cancer	0.000763	0.00188	CbGeAlD
Metformin—Flushing—Irinotecan—colon cancer	0.000761	0.00379	CcSEcCtD
Metformin—Cardiac disorder—Irinotecan—colon cancer	0.000761	0.00379	CcSEcCtD
Metformin—Mediastinal disorder—Vincristine—colon cancer	0.000759	0.00378	CcSEcCtD
Metformin—NDUFS2—bone marrow—colon cancer	0.000758	0.00187	CbGeAlD
Metformin—NDUFC2—vagina—colon cancer	0.000755	0.00186	CbGeAlD
Metformin—NDUFS3—bone marrow—colon cancer	0.000749	0.00185	CbGeAlD
Metformin—NDUFA2—lymph node—colon cancer	0.000748	0.00185	CbGeAlD
Metformin—Angiopathy—Irinotecan—colon cancer	0.000744	0.00371	CcSEcCtD
Metformin—Immune system disorder—Irinotecan—colon cancer	0.000741	0.00369	CcSEcCtD
Metformin—Mediastinal disorder—Irinotecan—colon cancer	0.000739	0.00368	CcSEcCtD
Metformin—NDUFS7—liver—colon cancer	0.000739	0.00183	CbGeAlD
Metformin—Dehydration—Capecitabine—colon cancer	0.000738	0.00368	CcSEcCtD
Metformin—Chills—Irinotecan—colon cancer	0.000736	0.00367	CcSEcCtD
Metformin—Liver function test abnormal—Capecitabine—colon cancer	0.000733	0.00365	CcSEcCtD
Metformin—NDUFS2—vagina—colon cancer	0.000726	0.00179	CbGeAlD
Metformin—Abdominal pain upper—Capecitabine—colon cancer	0.000725	0.00361	CcSEcCtD
Metformin—Breast disorder—Capecitabine—colon cancer	0.000717	0.00357	CcSEcCtD
Metformin—NDUFS3—vagina—colon cancer	0.000717	0.00177	CbGeAlD
Metformin—NDUFA10—lymph node—colon cancer	0.000713	0.00176	CbGeAlD
Metformin—Nasopharyngitis—Capecitabine—colon cancer	0.00071	0.00353	CcSEcCtD
Metformin—NDUFC1—lymph node—colon cancer	0.000707	0.00175	CbGeAlD
Metformin—Flatulence—Irinotecan—colon cancer	0.000704	0.00351	CcSEcCtD
Metformin—NDUFB2—lymph node—colon cancer	0.000701	0.00173	CbGeAlD
Metformin—NDUFAF1—lymph node—colon cancer	0.000695	0.00172	CbGeAlD
Metformin—Abdominal distension—Capecitabine—colon cancer	0.000691	0.00344	CcSEcCtD
Metformin—ND6—lymph node—colon cancer	0.00069	0.0017	CbGeAlD
Metformin—Muscle spasms—Irinotecan—colon cancer	0.000687	0.00342	CcSEcCtD
Metformin—Influenza—Capecitabine—colon cancer	0.000686	0.00342	CcSEcCtD
Metformin—Erythema—Fluorouracil—colon cancer	0.000684	0.00341	CcSEcCtD
Metformin—NDUFB3—lymph node—colon cancer	0.000684	0.00169	CbGeAlD
Metformin—NDUFAF2—lymph node—colon cancer	0.000684	0.00169	CbGeAlD
Metformin—ND1—lymphoid tissue—colon cancer	0.000683	0.00169	CbGeAlD
Metformin—PRKAB1—liver—colon cancer	0.000676	0.00167	CbGeAlD
Metformin—ND1—digestive system—colon cancer	0.000674	0.00167	CbGeAlD
Metformin—Angina pectoris—Capecitabine—colon cancer	0.000668	0.00333	CcSEcCtD
Metformin—Sweating increased—Capecitabine—colon cancer	0.000668	0.00333	CcSEcCtD
Metformin—NDUFA5—lymph node—colon cancer	0.000668	0.00165	CbGeAlD
Metformin—NDUFA11—lymph node—colon cancer	0.000668	0.00165	CbGeAlD
Metformin—NDUFB6—lymph node—colon cancer	0.000663	0.00164	CbGeAlD
Metformin—NDUFAF4—lymph node—colon cancer	0.000663	0.00164	CbGeAlD
Metformin—Ill-defined disorder—Irinotecan—colon cancer	0.000663	0.0033	CcSEcCtD
Metformin—SLC22A2—renal system—colon cancer	0.00066	0.00163	CbGeAlD
Metformin—NDUFS1—lymph node—colon cancer	0.000658	0.00163	CbGeAlD
Metformin—Abdominal discomfort—Capecitabine—colon cancer	0.000658	0.00328	CcSEcCtD
Metformin—NDUFB10—lymph node—colon cancer	0.000654	0.00161	CbGeAlD
Metformin—NDUFA12—lymph node—colon cancer	0.000649	0.0016	CbGeAlD
Metformin—NDUFB7—lymph node—colon cancer	0.000649	0.0016	CbGeAlD
Metformin—Vision blurred—Fluorouracil—colon cancer	0.000645	0.00321	CcSEcCtD
Metformin—NDUFB1—lymph node—colon cancer	0.000645	0.00159	CbGeAlD
Metformin—NDUFS8—lymph node—colon cancer	0.000645	0.00159	CbGeAlD
Metformin—Malaise—Irinotecan—colon cancer	0.000644	0.00321	CcSEcCtD
Metformin—Neutropenia—Capecitabine—colon cancer	0.000642	0.00319	CcSEcCtD
Metformin—Syncope—Irinotecan—colon cancer	0.000641	0.00319	CcSEcCtD
Metformin—Upper respiratory tract infection—Capecitabine—colon cancer	0.000638	0.00318	CcSEcCtD
Metformin—NDUFC2—liver—colon cancer	0.000637	0.00157	CbGeAlD
Metformin—NDUFB5—lymph node—colon cancer	0.000636	0.00157	CbGeAlD
Metformin—NDUFA6—lymph node—colon cancer	0.000636	0.00157	CbGeAlD
Metformin—Hypertension—Vincristine—colon cancer	0.000633	0.00315	CcSEcCtD
Metformin—NDUFS4—lymph node—colon cancer	0.000632	0.00156	CbGeAlD
Metformin—Loss of consciousness—Irinotecan—colon cancer	0.000628	0.00313	CcSEcCtD
Metformin—Myalgia—Vincristine—colon cancer	0.000624	0.00311	CcSEcCtD
Metformin—NDUFB4—lymph node—colon cancer	0.000624	0.00154	CbGeAlD
Metformin—ND1—bone marrow—colon cancer	0.000622	0.00154	CbGeAlD
Metformin—NDUFAB1—lymph node—colon cancer	0.00062	0.00153	CbGeAlD
Metformin—Hypertension—Irinotecan—colon cancer	0.000617	0.00307	CcSEcCtD
Metformin—NDUFA8—lymph node—colon cancer	0.000616	0.00152	CbGeAlD
Metformin—NDUFB9—lymph node—colon cancer	0.000616	0.00152	CbGeAlD
Metformin—NDUFS2—liver—colon cancer	0.000613	0.00151	CbGeAlD
Metformin—NDUFA4—lymph node—colon cancer	0.000612	0.00151	CbGeAlD
Metformin—Infestation NOS—Capecitabine—colon cancer	0.000612	0.00305	CcSEcCtD
Metformin—Infestation—Capecitabine—colon cancer	0.000612	0.00305	CcSEcCtD
Metformin—NDUFV1—lymph node—colon cancer	0.000608	0.0015	CbGeAlD
Metformin—NDUFB11—lymph node—colon cancer	0.000608	0.0015	CbGeAlD
Metformin—NDUFS3—liver—colon cancer	0.000605	0.00149	CbGeAlD
Metformin—NDUFB8—lymph node—colon cancer	0.000605	0.00149	CbGeAlD
Metformin—NDUFS5—lymph node—colon cancer	0.000605	0.00149	CbGeAlD
Metformin—Lethargy—Methotrexate—colon cancer	0.000603	0.003	CcSEcCtD
Metformin—Discomfort—Irinotecan—colon cancer	0.000601	0.00299	CcSEcCtD
Metformin—Neuropathy peripheral—Capecitabine—colon cancer	0.0006	0.00299	CcSEcCtD
Metformin—Oedema—Vincristine—colon cancer	0.000599	0.00298	CcSEcCtD
Metformin—Infection—Vincristine—colon cancer	0.000595	0.00296	CcSEcCtD
Metformin—SLC22A3—embryo—colon cancer	0.000589	0.00145	CbGeAlD
Metformin—Nervous system disorder—Vincristine—colon cancer	0.000587	0.00292	CcSEcCtD
Metformin—Thrombocytopenia—Vincristine—colon cancer	0.000586	0.00292	CcSEcCtD
Metformin—Oedema—Irinotecan—colon cancer	0.000583	0.0029	CcSEcCtD
Metformin—Chest pain—Fluorouracil—colon cancer	0.000582	0.0029	CcSEcCtD
Metformin—Myalgia—Fluorouracil—colon cancer	0.000582	0.0029	CcSEcCtD
Metformin—Infection—Irinotecan—colon cancer	0.000579	0.00288	CcSEcCtD
Metformin—Hyperhidrosis—Vincristine—colon cancer	0.000579	0.00288	CcSEcCtD
Metformin—Hepatobiliary disease—Capecitabine—colon cancer	0.000579	0.00288	CcSEcCtD
Metformin—Discomfort—Fluorouracil—colon cancer	0.000575	0.00287	CcSEcCtD
Metformin—Shock—Irinotecan—colon cancer	0.000574	0.00286	CcSEcCtD
Metformin—Nervous system disorder—Irinotecan—colon cancer	0.000572	0.00285	CcSEcCtD
Metformin—Thrombocytopenia—Irinotecan—colon cancer	0.000571	0.00284	CcSEcCtD
Metformin—Anorexia—Vincristine—colon cancer	0.000571	0.00284	CcSEcCtD
Metformin—NDUFS7—lymph node—colon cancer	0.000567	0.0014	CbGeAlD
Metformin—Hyperhidrosis—Irinotecan—colon cancer	0.000564	0.00281	CcSEcCtD
Metformin—Hypotension—Vincristine—colon cancer	0.000559	0.00279	CcSEcCtD
Metformin—Bradycardia—Capecitabine—colon cancer	0.000559	0.00278	CcSEcCtD
Metformin—SLC47A1—renal system—colon cancer	0.000559	0.00138	CbGeAlD
Metformin—Oedema—Fluorouracil—colon cancer	0.000558	0.00278	CcSEcCtD
Metformin—Anorexia—Irinotecan—colon cancer	0.000556	0.00277	CcSEcCtD
Metformin—Infection—Fluorouracil—colon cancer	0.000555	0.00276	CcSEcCtD
Metformin—Rhinitis—Capecitabine—colon cancer	0.000551	0.00274	CcSEcCtD
Metformin—Hepatitis—Capecitabine—colon cancer	0.000549	0.00273	CcSEcCtD
Metformin—Nervous system disorder—Fluorouracil—colon cancer	0.000548	0.00273	CcSEcCtD
Metformin—Thrombocytopenia—Fluorouracil—colon cancer	0.000547	0.00272	CcSEcCtD
Metformin—Hypoaesthesia—Capecitabine—colon cancer	0.000546	0.00272	CcSEcCtD
Metformin—Liver function test abnormal—Methotrexate—colon cancer	0.000546	0.00272	CcSEcCtD
Metformin—Musculoskeletal discomfort—Vincristine—colon cancer	0.000545	0.00272	CcSEcCtD
Metformin—Hypotension—Irinotecan—colon cancer	0.000545	0.00271	CcSEcCtD
Metformin—SLC22A2—digestive system—colon cancer	0.000541	0.00134	CbGeAlD
Metformin—Oedema peripheral—Capecitabine—colon cancer	0.000541	0.00269	CcSEcCtD
Metformin—Connective tissue disorder—Capecitabine—colon cancer	0.00054	0.00269	CcSEcCtD
Metformin—Paraesthesia—Vincristine—colon cancer	0.000537	0.00268	CcSEcCtD
Metformin—Breast disorder—Methotrexate—colon cancer	0.000534	0.00266	CcSEcCtD
Metformin—Anorexia—Fluorouracil—colon cancer	0.000532	0.00265	CcSEcCtD
Metformin—Paraesthesia—Irinotecan—colon cancer	0.000523	0.00261	CcSEcCtD
Metformin—Hypotension—Fluorouracil—colon cancer	0.000522	0.0026	CcSEcCtD
Metformin—Decreased appetite—Vincristine—colon cancer	0.00052	0.00259	CcSEcCtD
Metformin—Dyspnoea—Irinotecan—colon cancer	0.00052	0.00259	CcSEcCtD
Metformin—PRKAB1—lymph node—colon cancer	0.000518	0.00128	CbGeAlD
Metformin—Somnolence—Irinotecan—colon cancer	0.000518	0.00258	CcSEcCtD
Metformin—Gastrointestinal disorder—Vincristine—colon cancer	0.000517	0.00257	CcSEcCtD
Metformin—Fatigue—Vincristine—colon cancer	0.000516	0.00257	CcSEcCtD
Metformin—Eye disorder—Capecitabine—colon cancer	0.000513	0.00256	CcSEcCtD
Metformin—Dyspepsia—Irinotecan—colon cancer	0.000513	0.00256	CcSEcCtD
Metformin—Constipation—Vincristine—colon cancer	0.000512	0.00255	CcSEcCtD
Metformin—Flushing—Capecitabine—colon cancer	0.00051	0.00254	CcSEcCtD
Metformin—Cardiac disorder—Capecitabine—colon cancer	0.00051	0.00254	CcSEcCtD
Metformin—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000509	0.00253	CcSEcCtD
Metformin—Decreased appetite—Irinotecan—colon cancer	0.000507	0.00252	CcSEcCtD
Metformin—Gastrointestinal disorder—Irinotecan—colon cancer	0.000503	0.00251	CcSEcCtD
Metformin—Fatigue—Irinotecan—colon cancer	0.000503	0.0025	CcSEcCtD
Metformin—ND1—liver—colon cancer	0.000502	0.00124	CbGeAlD
Metformin—Paraesthesia—Fluorouracil—colon cancer	0.000501	0.0025	CcSEcCtD
Metformin—Pancreatitis—Methotrexate—colon cancer	0.000501	0.00249	CcSEcCtD
Metformin—Constipation—Irinotecan—colon cancer	0.000498	0.00248	CcSEcCtD
Metformin—Angiopathy—Capecitabine—colon cancer	0.000498	0.00248	CcSEcCtD
Metformin—Dyspnoea—Fluorouracil—colon cancer	0.000498	0.00248	CcSEcCtD
Metformin—Somnolence—Fluorouracil—colon cancer	0.000496	0.00247	CcSEcCtD
Metformin—Immune system disorder—Capecitabine—colon cancer	0.000496	0.00247	CcSEcCtD
Metformin—Mediastinal disorder—Capecitabine—colon cancer	0.000495	0.00246	CcSEcCtD
Metformin—Chills—Capecitabine—colon cancer	0.000493	0.00245	CcSEcCtD
Metformin—Dyspepsia—Fluorouracil—colon cancer	0.000491	0.00245	CcSEcCtD
Metformin—Abdominal discomfort—Methotrexate—colon cancer	0.00049	0.00244	CcSEcCtD
Metformin—Gastrointestinal pain—Vincristine—colon cancer	0.000489	0.00244	CcSEcCtD
Metformin—NDUFC2—lymph node—colon cancer	0.000488	0.00121	CbGeAlD
Metformin—Decreased appetite—Fluorouracil—colon cancer	0.000485	0.00242	CcSEcCtD
Metformin—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000482	0.0024	CcSEcCtD
Metformin—Feeling abnormal—Irinotecan—colon cancer	0.00048	0.00239	CcSEcCtD
Metformin—Erythema—Capecitabine—colon cancer	0.000478	0.00238	CcSEcCtD
Metformin—Malnutrition—Capecitabine—colon cancer	0.000478	0.00238	CcSEcCtD
Metformin—Neutropenia—Methotrexate—colon cancer	0.000478	0.00238	CcSEcCtD
Metformin—Gastrointestinal pain—Irinotecan—colon cancer	0.000477	0.00237	CcSEcCtD
Metformin—Upper respiratory tract infection—Methotrexate—colon cancer	0.000475	0.00236	CcSEcCtD
Metformin—Abdominal pain—Vincristine—colon cancer	0.000473	0.00236	CcSEcCtD
Metformin—Flatulence—Capecitabine—colon cancer	0.000471	0.00235	CcSEcCtD
Metformin—NDUFS2—lymph node—colon cancer	0.00047	0.00116	CbGeAlD
Metformin—Dysgeusia—Capecitabine—colon cancer	0.000468	0.00233	CcSEcCtD
Metformin—SLC22A1—renal system—colon cancer	0.000466	0.00115	CbGeAlD
Metformin—NDUFS3—lymph node—colon cancer	0.000464	0.00115	CbGeAlD
Metformin—SLC22A3—smooth muscle tissue—colon cancer	0.000463	0.00114	CbGeAlD
Metformin—Abdominal pain—Irinotecan—colon cancer	0.000461	0.00229	CcSEcCtD
Metformin—Feeling abnormal—Fluorouracil—colon cancer	0.00046	0.00229	CcSEcCtD
Metformin—Muscle spasms—Capecitabine—colon cancer	0.00046	0.00229	CcSEcCtD
Metformin—SLC47A1—digestive system—colon cancer	0.000458	0.00113	CbGeAlD
Metformin—Infestation—Methotrexate—colon cancer	0.000455	0.00227	CcSEcCtD
Metformin—Infestation NOS—Methotrexate—colon cancer	0.000455	0.00227	CcSEcCtD
Metformin—Drowsiness—Methotrexate—colon cancer	0.000455	0.00227	CcSEcCtD
Metformin—Vision blurred—Capecitabine—colon cancer	0.000451	0.00224	CcSEcCtD
Metformin—Tremor—Capecitabine—colon cancer	0.000448	0.00223	CcSEcCtD
Metformin—SLC22A3—renal system—colon cancer	0.000446	0.0011	CbGeAlD
Metformin—Ill-defined disorder—Capecitabine—colon cancer	0.000444	0.00221	CcSEcCtD
Metformin—Urticaria—Fluorouracil—colon cancer	0.000444	0.00221	CcSEcCtD
Metformin—Malaise—Capecitabine—colon cancer	0.000431	0.00215	CcSEcCtD
Metformin—Hepatobiliary disease—Methotrexate—colon cancer	0.000431	0.00214	CcSEcCtD
Metformin—Asthenia—Vincristine—colon cancer	0.000429	0.00214	CcSEcCtD
Metformin—Syncope—Capecitabine—colon cancer	0.000429	0.00213	CcSEcCtD
Metformin—Palpitations—Capecitabine—colon cancer	0.000422	0.0021	CcSEcCtD
Metformin—Loss of consciousness—Capecitabine—colon cancer	0.00042	0.00209	CcSEcCtD
Metformin—Asthenia—Irinotecan—colon cancer	0.000418	0.00208	CcSEcCtD
Metformin—Hypertension—Capecitabine—colon cancer	0.000413	0.00206	CcSEcCtD
Metformin—Diarrhoea—Vincristine—colon cancer	0.00041	0.00204	CcSEcCtD
Metformin—Hepatitis—Methotrexate—colon cancer	0.000409	0.00204	CcSEcCtD
Metformin—Chest pain—Capecitabine—colon cancer	0.000407	0.00203	CcSEcCtD
Metformin—Myalgia—Capecitabine—colon cancer	0.000407	0.00203	CcSEcCtD
Metformin—SLC47A1—vagina—colon cancer	0.000405	0.000999	CbGeAlD
Metformin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000404	0.00201	CcSEcCtD
Metformin—Discomfort—Capecitabine—colon cancer	0.000402	0.002	CcSEcCtD
Metformin—Diarrhoea—Irinotecan—colon cancer	0.000399	0.00199	CcSEcCtD
Metformin—Dizziness—Vincristine—colon cancer	0.000396	0.00197	CcSEcCtD
Metformin—Pruritus—Fluorouracil—colon cancer	0.000395	0.00197	CcSEcCtD
Metformin—Oedema—Capecitabine—colon cancer	0.00039	0.00194	CcSEcCtD
Metformin—Infection—Capecitabine—colon cancer	0.000388	0.00193	CcSEcCtD
Metformin—Dizziness—Irinotecan—colon cancer	0.000385	0.00192	CcSEcCtD
Metformin—ND1—lymph node—colon cancer	0.000385	0.000951	CbGeAlD
Metformin—Shock—Capecitabine—colon cancer	0.000384	0.00191	CcSEcCtD
Metformin—Nervous system disorder—Capecitabine—colon cancer	0.000383	0.00191	CcSEcCtD
Metformin—Eye disorder—Methotrexate—colon cancer	0.000382	0.0019	CcSEcCtD
Metformin—Diarrhoea—Fluorouracil—colon cancer	0.000382	0.0019	CcSEcCtD
Metformin—Thrombocytopenia—Capecitabine—colon cancer	0.000382	0.0019	CcSEcCtD
Metformin—Vomiting—Vincristine—colon cancer	0.000381	0.0019	CcSEcCtD
Metformin—Cardiac disorder—Methotrexate—colon cancer	0.000379	0.00189	CcSEcCtD
Metformin—Skin disorder—Capecitabine—colon cancer	0.000379	0.00189	CcSEcCtD
Metformin—Rash—Vincristine—colon cancer	0.000377	0.00188	CcSEcCtD
Metformin—Hyperhidrosis—Capecitabine—colon cancer	0.000377	0.00188	CcSEcCtD
Metformin—Dermatitis—Vincristine—colon cancer	0.000377	0.00188	CcSEcCtD
Metformin—Headache—Vincristine—colon cancer	0.000375	0.00187	CcSEcCtD
Metformin—Anorexia—Capecitabine—colon cancer	0.000372	0.00185	CcSEcCtD
Metformin—Angiopathy—Methotrexate—colon cancer	0.000371	0.00185	CcSEcCtD
Metformin—Vomiting—Irinotecan—colon cancer	0.000371	0.00185	CcSEcCtD
Metformin—Immune system disorder—Methotrexate—colon cancer	0.000369	0.00184	CcSEcCtD
Metformin—Dizziness—Fluorouracil—colon cancer	0.000369	0.00184	CcSEcCtD
Metformin—Mediastinal disorder—Methotrexate—colon cancer	0.000368	0.00183	CcSEcCtD
Metformin—Rash—Irinotecan—colon cancer	0.000368	0.00183	CcSEcCtD
Metformin—Dermatitis—Irinotecan—colon cancer	0.000367	0.00183	CcSEcCtD
Metformin—Chills—Methotrexate—colon cancer	0.000367	0.00183	CcSEcCtD
Metformin—Headache—Irinotecan—colon cancer	0.000365	0.00182	CcSEcCtD
Metformin—Hypotension—Capecitabine—colon cancer	0.000365	0.00182	CcSEcCtD
Metformin—Erythema—Methotrexate—colon cancer	0.000356	0.00177	CcSEcCtD
Metformin—Malnutrition—Methotrexate—colon cancer	0.000356	0.00177	CcSEcCtD
Metformin—Nausea—Vincristine—colon cancer	0.000356	0.00177	CcSEcCtD
Metformin—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000355	0.00177	CcSEcCtD
Metformin—Vomiting—Fluorouracil—colon cancer	0.000355	0.00177	CcSEcCtD
Metformin—Rash—Fluorouracil—colon cancer	0.000352	0.00175	CcSEcCtD
Metformin—Dermatitis—Fluorouracil—colon cancer	0.000352	0.00175	CcSEcCtD
Metformin—Paraesthesia—Capecitabine—colon cancer	0.00035	0.00174	CcSEcCtD
Metformin—Headache—Fluorouracil—colon cancer	0.00035	0.00174	CcSEcCtD
Metformin—Dysgeusia—Methotrexate—colon cancer	0.000348	0.00174	CcSEcCtD
Metformin—Dyspnoea—Capecitabine—colon cancer	0.000348	0.00173	CcSEcCtD
Metformin—Nausea—Irinotecan—colon cancer	0.000346	0.00172	CcSEcCtD
Metformin—Dyspepsia—Capecitabine—colon cancer	0.000343	0.00171	CcSEcCtD
Metformin—SLC47A1—liver—colon cancer	0.000341	0.000843	CbGeAlD
Metformin—Decreased appetite—Capecitabine—colon cancer	0.000339	0.00169	CcSEcCtD
Metformin—SLC22A1—vagina—colon cancer	0.000338	0.000834	CbGeAlD
Metformin—Gastrointestinal disorder—Capecitabine—colon cancer	0.000337	0.00168	CcSEcCtD
Metformin—Fatigue—Capecitabine—colon cancer	0.000336	0.00168	CcSEcCtD
Metformin—Vision blurred—Methotrexate—colon cancer	0.000335	0.00167	CcSEcCtD
Metformin—Constipation—Capecitabine—colon cancer	0.000334	0.00166	CcSEcCtD
Metformin—Nausea—Fluorouracil—colon cancer	0.000332	0.00165	CcSEcCtD
Metformin—Ill-defined disorder—Methotrexate—colon cancer	0.00033	0.00164	CcSEcCtD
Metformin—SLC22A3—vagina—colon cancer	0.000323	0.000797	CbGeAlD
Metformin—Feeling abnormal—Capecitabine—colon cancer	0.000322	0.0016	CcSEcCtD
Metformin—Malaise—Methotrexate—colon cancer	0.000321	0.0016	CcSEcCtD
Metformin—Gastrointestinal pain—Capecitabine—colon cancer	0.000319	0.00159	CcSEcCtD
Metformin—Urticaria—Capecitabine—colon cancer	0.00031	0.00154	CcSEcCtD
Metformin—Abdominal pain—Capecitabine—colon cancer	0.000308	0.00154	CcSEcCtD
Metformin—Chest pain—Methotrexate—colon cancer	0.000303	0.00151	CcSEcCtD
Metformin—Myalgia—Methotrexate—colon cancer	0.000303	0.00151	CcSEcCtD
Metformin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000301	0.0015	CcSEcCtD
Metformin—Discomfort—Methotrexate—colon cancer	0.000299	0.00149	CcSEcCtD
Metformin—Infection—Methotrexate—colon cancer	0.000289	0.00144	CcSEcCtD
Metformin—SLC22A1—liver—colon cancer	0.000285	0.000703	CbGeAlD
Metformin—Nervous system disorder—Methotrexate—colon cancer	0.000285	0.00142	CcSEcCtD
Metformin—Thrombocytopenia—Methotrexate—colon cancer	0.000284	0.00142	CcSEcCtD
Metformin—Skin disorder—Methotrexate—colon cancer	0.000282	0.0014	CcSEcCtD
Metformin—Hyperhidrosis—Methotrexate—colon cancer	0.000281	0.0014	CcSEcCtD
Metformin—Asthenia—Capecitabine—colon cancer	0.00028	0.00139	CcSEcCtD
Metformin—Anorexia—Methotrexate—colon cancer	0.000277	0.00138	CcSEcCtD
Metformin—Pruritus—Capecitabine—colon cancer	0.000276	0.00137	CcSEcCtD
Metformin—SLC22A3—liver—colon cancer	0.000272	0.000672	CbGeAlD
Metformin—Hypotension—Methotrexate—colon cancer	0.000271	0.00135	CcSEcCtD
Metformin—Diarrhoea—Capecitabine—colon cancer	0.000267	0.00133	CcSEcCtD
Metformin—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000265	0.00132	CcSEcCtD
Metformin—SLC47A1—lymph node—colon cancer	0.000262	0.000646	CbGeAlD
Metformin—Paraesthesia—Methotrexate—colon cancer	0.000261	0.0013	CcSEcCtD
Metformin—Dyspnoea—Methotrexate—colon cancer	0.000259	0.00129	CcSEcCtD
Metformin—Somnolence—Methotrexate—colon cancer	0.000258	0.00129	CcSEcCtD
Metformin—Dizziness—Capecitabine—colon cancer	0.000258	0.00128	CcSEcCtD
Metformin—Dyspepsia—Methotrexate—colon cancer	0.000256	0.00127	CcSEcCtD
Metformin—Decreased appetite—Methotrexate—colon cancer	0.000252	0.00126	CcSEcCtD
Metformin—Gastrointestinal disorder—Methotrexate—colon cancer	0.000251	0.00125	CcSEcCtD
Metformin—Fatigue—Methotrexate—colon cancer	0.00025	0.00125	CcSEcCtD
Metformin—Vomiting—Capecitabine—colon cancer	0.000248	0.00124	CcSEcCtD
Metformin—Rash—Capecitabine—colon cancer	0.000246	0.00123	CcSEcCtD
Metformin—Dermatitis—Capecitabine—colon cancer	0.000246	0.00122	CcSEcCtD
Metformin—Headache—Capecitabine—colon cancer	0.000244	0.00122	CcSEcCtD
Metformin—Feeling abnormal—Methotrexate—colon cancer	0.000239	0.00119	CcSEcCtD
Metformin—Gastrointestinal pain—Methotrexate—colon cancer	0.000237	0.00118	CcSEcCtD
Metformin—Nausea—Capecitabine—colon cancer	0.000232	0.00115	CcSEcCtD
Metformin—Urticaria—Methotrexate—colon cancer	0.000231	0.00115	CcSEcCtD
Metformin—Abdominal pain—Methotrexate—colon cancer	0.00023	0.00114	CcSEcCtD
Metformin—SLC22A3—lymph node—colon cancer	0.000209	0.000515	CbGeAlD
Metformin—Asthenia—Methotrexate—colon cancer	0.000208	0.00104	CcSEcCtD
Metformin—Pruritus—Methotrexate—colon cancer	0.000205	0.00102	CcSEcCtD
Metformin—Diarrhoea—Methotrexate—colon cancer	0.000199	0.00099	CcSEcCtD
Metformin—Dizziness—Methotrexate—colon cancer	0.000192	0.000956	CcSEcCtD
Metformin—Vomiting—Methotrexate—colon cancer	0.000185	0.00092	CcSEcCtD
Metformin—Rash—Methotrexate—colon cancer	0.000183	0.000912	CcSEcCtD
Metformin—Dermatitis—Methotrexate—colon cancer	0.000183	0.000911	CcSEcCtD
Metformin—Headache—Methotrexate—colon cancer	0.000182	0.000906	CcSEcCtD
Metformin—Nausea—Methotrexate—colon cancer	0.000173	0.000859	CcSEcCtD
Metformin—NDUFA9—Metabolism—PPARG—colon cancer	0.000101	0.00054	CbGpPWpGaD
Metformin—ND4L—Metabolism—PPARG—colon cancer	0.000101	0.00054	CbGpPWpGaD
Metformin—ND5—Metabolism—PPARG—colon cancer	0.000101	0.00054	CbGpPWpGaD
Metformin—NDUFS8—Metabolism—PPARG—colon cancer	0.000101	0.00054	CbGpPWpGaD
Metformin—NDUFA4—Metabolism—PPARG—colon cancer	0.000101	0.00054	CbGpPWpGaD
Metformin—NDUFA6—Metabolism—PPARG—colon cancer	0.000101	0.00054	CbGpPWpGaD
Metformin—PRKAB1—Membrane Trafficking—AKT1—colon cancer	9.68e-05	0.000519	CbGpPWpGaD
Metformin—NDUFB11—Metabolism—PTGS2—colon cancer	9.31e-05	0.000499	CbGpPWpGaD
Metformin—NDUFV3—Metabolism—PPARG—colon cancer	8.97e-05	0.000481	CbGpPWpGaD
Metformin—NDUFA1—Metabolism—PTGS2—colon cancer	8.51e-05	0.000457	CbGpPWpGaD
Metformin—NDUFA12—Metabolism—PTGS2—colon cancer	8.51e-05	0.000457	CbGpPWpGaD
Metformin—NDUFA11—Metabolism—PTGS2—colon cancer	8.51e-05	0.000457	CbGpPWpGaD
Metformin—NDUFB3—Metabolism—PTGS2—colon cancer	8.51e-05	0.000457	CbGpPWpGaD
Metformin—NDUFC1—Metabolism—PTGS2—colon cancer	7.92e-05	0.000425	CbGpPWpGaD
Metformin—ND4—Metabolism—PTGS2—colon cancer	7.92e-05	0.000425	CbGpPWpGaD
Metformin—NDUFV2—Metabolism—PTGS2—colon cancer	7.92e-05	0.000425	CbGpPWpGaD
Metformin—NDUFB4—Metabolism—PTGS2—colon cancer	7.92e-05	0.000425	CbGpPWpGaD
Metformin—NDUFB2—Metabolism—PTGS2—colon cancer	7.92e-05	0.000425	CbGpPWpGaD
Metformin—NDUFB6—Metabolism—PTGS2—colon cancer	7.92e-05	0.000425	CbGpPWpGaD
Metformin—NDUFS4—Metabolism—PTGS2—colon cancer	7.92e-05	0.000425	CbGpPWpGaD
Metformin—ND3—Metabolism—PTGS2—colon cancer	7.92e-05	0.000425	CbGpPWpGaD
Metformin—NDUFB7—Metabolism—PTGS2—colon cancer	7.92e-05	0.000425	CbGpPWpGaD
Metformin—NDUFA7—Metabolism—PTGS2—colon cancer	7.92e-05	0.000425	CbGpPWpGaD
Metformin—NDUFA3—Metabolism—PTGS2—colon cancer	7.92e-05	0.000425	CbGpPWpGaD
Metformin—NDUFA9—Metabolism—PTGS2—colon cancer	7.92e-05	0.000425	CbGpPWpGaD
Metformin—NDUFA10—Metabolism—PTGS2—colon cancer	7.92e-05	0.000425	CbGpPWpGaD
Metformin—ND2—Metabolism—PTGS2—colon cancer	7.92e-05	0.000425	CbGpPWpGaD
Metformin—NDUFB9—Metabolism—PTGS2—colon cancer	7.92e-05	0.000425	CbGpPWpGaD
Metformin—NDUFB10—Metabolism—PTGS2—colon cancer	7.92e-05	0.000425	CbGpPWpGaD
Metformin—NDUFAB1—Metabolism—PTGS2—colon cancer	7.92e-05	0.000425	CbGpPWpGaD
Metformin—NDUFA5—Metabolism—PTGS2—colon cancer	7.92e-05	0.000425	CbGpPWpGaD
Metformin—NDUFA13—Metabolism—PTGS2—colon cancer	7.92e-05	0.000425	CbGpPWpGaD
Metformin—NDUFS5—Metabolism—PTGS2—colon cancer	7.92e-05	0.000425	CbGpPWpGaD
Metformin—NDUFV1—Metabolism—PTGS2—colon cancer	7.92e-05	0.000425	CbGpPWpGaD
Metformin—NDUFS1—Metabolism—PTGS2—colon cancer	7.92e-05	0.000425	CbGpPWpGaD
Metformin—NDUFB5—Metabolism—PTGS2—colon cancer	7.92e-05	0.000425	CbGpPWpGaD
Metformin—NDUFB8—Metabolism—PTGS2—colon cancer	7.92e-05	0.000425	CbGpPWpGaD
Metformin—ND6—Metabolism—PTGS2—colon cancer	7.92e-05	0.000425	CbGpPWpGaD
Metformin—NDUFA4—Metabolism—PTGS2—colon cancer	7.92e-05	0.000425	CbGpPWpGaD
Metformin—NDUFB1—Metabolism—PTGS2—colon cancer	7.92e-05	0.000425	CbGpPWpGaD
Metformin—NDUFA8—Metabolism—PTGS2—colon cancer	7.92e-05	0.000425	CbGpPWpGaD
Metformin—ND5—Metabolism—PTGS2—colon cancer	7.92e-05	0.000425	CbGpPWpGaD
Metformin—NDUFS6—Metabolism—PTGS2—colon cancer	7.92e-05	0.000425	CbGpPWpGaD
Metformin—NDUFA6—Metabolism—PTGS2—colon cancer	7.92e-05	0.000425	CbGpPWpGaD
Metformin—ND4L—Metabolism—PTGS2—colon cancer	7.92e-05	0.000425	CbGpPWpGaD
Metformin—NDUFA2—Metabolism—PTGS2—colon cancer	7.92e-05	0.000425	CbGpPWpGaD
Metformin—NDUFS8—Metabolism—PTGS2—colon cancer	7.92e-05	0.000425	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—ODC1—colon cancer	7.81e-05	0.000419	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—CHST5—colon cancer	7.81e-05	0.000419	CbGpPWpGaD
Metformin—NDUFB11—Metabolism—EP300—colon cancer	7.74e-05	0.000415	CbGpPWpGaD
Metformin—NDUFC2—Metabolism—PPARG—colon cancer	7.63e-05	0.000409	CbGpPWpGaD
Metformin—NDUFS3—Metabolism—PPARG—colon cancer	7.63e-05	0.000409	CbGpPWpGaD
Metformin—NDUFS7—Metabolism—PPARG—colon cancer	7.63e-05	0.000409	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—CHST5—colon cancer	7.28e-05	0.000391	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—ODC1—colon cancer	7.28e-05	0.000391	CbGpPWpGaD
Metformin—SLC22A2—Transmission across Chemical Synapses—BRAF—colon cancer	7.25e-05	0.000389	CbGpPWpGaD
Metformin—NDUFS2—Metabolism—PPARG—colon cancer	7.17e-05	0.000385	CbGpPWpGaD
Metformin—NDUFA11—Metabolism—EP300—colon cancer	7.08e-05	0.00038	CbGpPWpGaD
Metformin—NDUFA12—Metabolism—EP300—colon cancer	7.08e-05	0.00038	CbGpPWpGaD
Metformin—NDUFA1—Metabolism—EP300—colon cancer	7.08e-05	0.00038	CbGpPWpGaD
Metformin—NDUFB3—Metabolism—EP300—colon cancer	7.08e-05	0.00038	CbGpPWpGaD
Metformin—ND1—Metabolism—ABCB1—colon cancer	7.06e-05	0.000379	CbGpPWpGaD
Metformin—NDUFV3—Metabolism—PTGS2—colon cancer	7.05e-05	0.000379	CbGpPWpGaD
Metformin—SLC22A3—Transmembrane transport of small molecules—ABCB1—colon cancer	7.03e-05	0.000377	CbGpPWpGaD
Metformin—ND1—Metabolism—TYMS—colon cancer	6.94e-05	0.000372	CbGpPWpGaD
Metformin—SLC22A1—Transmission across Chemical Synapses—BRAF—colon cancer	6.75e-05	0.000362	CbGpPWpGaD
Metformin—NDUFA4—Metabolism—EP300—colon cancer	6.58e-05	0.000353	CbGpPWpGaD
Metformin—NDUFA5—Metabolism—EP300—colon cancer	6.58e-05	0.000353	CbGpPWpGaD
Metformin—NDUFS6—Metabolism—EP300—colon cancer	6.58e-05	0.000353	CbGpPWpGaD
Metformin—NDUFB6—Metabolism—EP300—colon cancer	6.58e-05	0.000353	CbGpPWpGaD
Metformin—ND6—Metabolism—EP300—colon cancer	6.58e-05	0.000353	CbGpPWpGaD
Metformin—ND4—Metabolism—EP300—colon cancer	6.58e-05	0.000353	CbGpPWpGaD
Metformin—NDUFB2—Metabolism—EP300—colon cancer	6.58e-05	0.000353	CbGpPWpGaD
Metformin—ND3—Metabolism—EP300—colon cancer	6.58e-05	0.000353	CbGpPWpGaD
Metformin—NDUFV1—Metabolism—EP300—colon cancer	6.58e-05	0.000353	CbGpPWpGaD
Metformin—NDUFB10—Metabolism—EP300—colon cancer	6.58e-05	0.000353	CbGpPWpGaD
Metformin—NDUFB9—Metabolism—EP300—colon cancer	6.58e-05	0.000353	CbGpPWpGaD
Metformin—NDUFA2—Metabolism—EP300—colon cancer	6.58e-05	0.000353	CbGpPWpGaD
Metformin—NDUFA6—Metabolism—EP300—colon cancer	6.58e-05	0.000353	CbGpPWpGaD
Metformin—ND5—Metabolism—EP300—colon cancer	6.58e-05	0.000353	CbGpPWpGaD
Metformin—ND4L—Metabolism—EP300—colon cancer	6.58e-05	0.000353	CbGpPWpGaD
Metformin—NDUFB4—Metabolism—EP300—colon cancer	6.58e-05	0.000353	CbGpPWpGaD
Metformin—NDUFA10—Metabolism—EP300—colon cancer	6.58e-05	0.000353	CbGpPWpGaD
Metformin—NDUFA9—Metabolism—EP300—colon cancer	6.58e-05	0.000353	CbGpPWpGaD
Metformin—NDUFB7—Metabolism—EP300—colon cancer	6.58e-05	0.000353	CbGpPWpGaD
Metformin—NDUFS5—Metabolism—EP300—colon cancer	6.58e-05	0.000353	CbGpPWpGaD
Metformin—NDUFS1—Metabolism—EP300—colon cancer	6.58e-05	0.000353	CbGpPWpGaD
Metformin—NDUFB8—Metabolism—EP300—colon cancer	6.58e-05	0.000353	CbGpPWpGaD
Metformin—NDUFB1—Metabolism—EP300—colon cancer	6.58e-05	0.000353	CbGpPWpGaD
Metformin—NDUFA13—Metabolism—EP300—colon cancer	6.58e-05	0.000353	CbGpPWpGaD
Metformin—NDUFC1—Metabolism—EP300—colon cancer	6.58e-05	0.000353	CbGpPWpGaD
Metformin—NDUFAB1—Metabolism—EP300—colon cancer	6.58e-05	0.000353	CbGpPWpGaD
Metformin—NDUFB5—Metabolism—EP300—colon cancer	6.58e-05	0.000353	CbGpPWpGaD
Metformin—NDUFA8—Metabolism—EP300—colon cancer	6.58e-05	0.000353	CbGpPWpGaD
Metformin—NDUFS8—Metabolism—EP300—colon cancer	6.58e-05	0.000353	CbGpPWpGaD
Metformin—ND2—Metabolism—EP300—colon cancer	6.58e-05	0.000353	CbGpPWpGaD
Metformin—NDUFS4—Metabolism—EP300—colon cancer	6.58e-05	0.000353	CbGpPWpGaD
Metformin—NDUFA3—Metabolism—EP300—colon cancer	6.58e-05	0.000353	CbGpPWpGaD
Metformin—NDUFA7—Metabolism—EP300—colon cancer	6.58e-05	0.000353	CbGpPWpGaD
Metformin—NDUFV2—Metabolism—EP300—colon cancer	6.58e-05	0.000353	CbGpPWpGaD
Metformin—NDUFS7—Metabolism—PTGS2—colon cancer	6e-05	0.000322	CbGpPWpGaD
Metformin—NDUFS3—Metabolism—PTGS2—colon cancer	6e-05	0.000322	CbGpPWpGaD
Metformin—NDUFC2—Metabolism—PTGS2—colon cancer	6e-05	0.000322	CbGpPWpGaD
Metformin—NDUFV3—Metabolism—EP300—colon cancer	5.87e-05	0.000315	CbGpPWpGaD
Metformin—NDUFB11—Metabolism—PIK3CA—colon cancer	5.73e-05	0.000307	CbGpPWpGaD
Metformin—NDUFS2—Metabolism—PTGS2—colon cancer	5.64e-05	0.000303	CbGpPWpGaD
Metformin—SLC22A2—Neuronal System—BRAF—colon cancer	5.55e-05	0.000298	CbGpPWpGaD
Metformin—NDUFA11—Metabolism—PIK3CA—colon cancer	5.24e-05	0.000281	CbGpPWpGaD
Metformin—NDUFB3—Metabolism—PIK3CA—colon cancer	5.24e-05	0.000281	CbGpPWpGaD
Metformin—NDUFA12—Metabolism—PIK3CA—colon cancer	5.24e-05	0.000281	CbGpPWpGaD
Metformin—NDUFA1—Metabolism—PIK3CA—colon cancer	5.24e-05	0.000281	CbGpPWpGaD
Metformin—SLC22A1—Neuronal System—BRAF—colon cancer	5.18e-05	0.000278	CbGpPWpGaD
Metformin—NDUFS7—Metabolism—EP300—colon cancer	4.99e-05	0.000268	CbGpPWpGaD
Metformin—NDUFS3—Metabolism—EP300—colon cancer	4.99e-05	0.000268	CbGpPWpGaD
Metformin—NDUFC2—Metabolism—EP300—colon cancer	4.99e-05	0.000268	CbGpPWpGaD
Metformin—ND1—Metabolism—PPARG—colon cancer	4.91e-05	0.000264	CbGpPWpGaD
Metformin—NDUFB7—Metabolism—PIK3CA—colon cancer	4.87e-05	0.000261	CbGpPWpGaD
Metformin—NDUFB2—Metabolism—PIK3CA—colon cancer	4.87e-05	0.000261	CbGpPWpGaD
Metformin—NDUFV1—Metabolism—PIK3CA—colon cancer	4.87e-05	0.000261	CbGpPWpGaD
Metformin—NDUFS1—Metabolism—PIK3CA—colon cancer	4.87e-05	0.000261	CbGpPWpGaD
Metformin—ND3—Metabolism—PIK3CA—colon cancer	4.87e-05	0.000261	CbGpPWpGaD
Metformin—NDUFA4—Metabolism—PIK3CA—colon cancer	4.87e-05	0.000261	CbGpPWpGaD
Metformin—ND4—Metabolism—PIK3CA—colon cancer	4.87e-05	0.000261	CbGpPWpGaD
Metformin—NDUFA10—Metabolism—PIK3CA—colon cancer	4.87e-05	0.000261	CbGpPWpGaD
Metformin—ND5—Metabolism—PIK3CA—colon cancer	4.87e-05	0.000261	CbGpPWpGaD
Metformin—NDUFA9—Metabolism—PIK3CA—colon cancer	4.87e-05	0.000261	CbGpPWpGaD
Metformin—NDUFB6—Metabolism—PIK3CA—colon cancer	4.87e-05	0.000261	CbGpPWpGaD
Metformin—NDUFB1—Metabolism—PIK3CA—colon cancer	4.87e-05	0.000261	CbGpPWpGaD
Metformin—NDUFA5—Metabolism—PIK3CA—colon cancer	4.87e-05	0.000261	CbGpPWpGaD
Metformin—NDUFC1—Metabolism—PIK3CA—colon cancer	4.87e-05	0.000261	CbGpPWpGaD
Metformin—NDUFB10—Metabolism—PIK3CA—colon cancer	4.87e-05	0.000261	CbGpPWpGaD
Metformin—NDUFA8—Metabolism—PIK3CA—colon cancer	4.87e-05	0.000261	CbGpPWpGaD
Metformin—NDUFB5—Metabolism—PIK3CA—colon cancer	4.87e-05	0.000261	CbGpPWpGaD
Metformin—NDUFA7—Metabolism—PIK3CA—colon cancer	4.87e-05	0.000261	CbGpPWpGaD
Metformin—ND4L—Metabolism—PIK3CA—colon cancer	4.87e-05	0.000261	CbGpPWpGaD
Metformin—NDUFS4—Metabolism—PIK3CA—colon cancer	4.87e-05	0.000261	CbGpPWpGaD
Metformin—ND6—Metabolism—PIK3CA—colon cancer	4.87e-05	0.000261	CbGpPWpGaD
Metformin—NDUFS8—Metabolism—PIK3CA—colon cancer	4.87e-05	0.000261	CbGpPWpGaD
Metformin—NDUFB8—Metabolism—PIK3CA—colon cancer	4.87e-05	0.000261	CbGpPWpGaD
Metformin—NDUFAB1—Metabolism—PIK3CA—colon cancer	4.87e-05	0.000261	CbGpPWpGaD
Metformin—ND2—Metabolism—PIK3CA—colon cancer	4.87e-05	0.000261	CbGpPWpGaD
Metformin—NDUFS5—Metabolism—PIK3CA—colon cancer	4.87e-05	0.000261	CbGpPWpGaD
Metformin—NDUFA6—Metabolism—PIK3CA—colon cancer	4.87e-05	0.000261	CbGpPWpGaD
Metformin—NDUFV2—Metabolism—PIK3CA—colon cancer	4.87e-05	0.000261	CbGpPWpGaD
Metformin—NDUFA2—Metabolism—PIK3CA—colon cancer	4.87e-05	0.000261	CbGpPWpGaD
Metformin—NDUFB4—Metabolism—PIK3CA—colon cancer	4.87e-05	0.000261	CbGpPWpGaD
Metformin—NDUFB9—Metabolism—PIK3CA—colon cancer	4.87e-05	0.000261	CbGpPWpGaD
Metformin—NDUFA3—Metabolism—PIK3CA—colon cancer	4.87e-05	0.000261	CbGpPWpGaD
Metformin—NDUFS6—Metabolism—PIK3CA—colon cancer	4.87e-05	0.000261	CbGpPWpGaD
Metformin—NDUFA13—Metabolism—PIK3CA—colon cancer	4.87e-05	0.000261	CbGpPWpGaD
Metformin—NDUFS2—Metabolism—EP300—colon cancer	4.69e-05	0.000252	CbGpPWpGaD
Metformin—NDUFB11—Metabolism—AKT1—colon cancer	4.68e-05	0.000251	CbGpPWpGaD
Metformin—SLC22A2—Transmembrane transport of small molecules—ABCB1—colon cancer	4.41e-05	0.000236	CbGpPWpGaD
Metformin—NDUFV3—Metabolism—PIK3CA—colon cancer	4.34e-05	0.000233	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—FGFR3—colon cancer	4.28e-05	0.00023	CbGpPWpGaD
Metformin—NDUFA11—Metabolism—AKT1—colon cancer	4.28e-05	0.00023	CbGpPWpGaD
Metformin—NDUFA1—Metabolism—AKT1—colon cancer	4.28e-05	0.00023	CbGpPWpGaD
Metformin—NDUFA12—Metabolism—AKT1—colon cancer	4.28e-05	0.00023	CbGpPWpGaD
Metformin—NDUFB3—Metabolism—AKT1—colon cancer	4.28e-05	0.00023	CbGpPWpGaD
Metformin—SLC22A1—Transmembrane transport of small molecules—ABCB1—colon cancer	4.11e-05	0.00022	CbGpPWpGaD
Metformin—NDUFB2—Metabolism—AKT1—colon cancer	3.98e-05	0.000213	CbGpPWpGaD
Metformin—NDUFS8—Metabolism—AKT1—colon cancer	3.98e-05	0.000213	CbGpPWpGaD
Metformin—NDUFB9—Metabolism—AKT1—colon cancer	3.98e-05	0.000213	CbGpPWpGaD
Metformin—NDUFA13—Metabolism—AKT1—colon cancer	3.98e-05	0.000213	CbGpPWpGaD
Metformin—NDUFA8—Metabolism—AKT1—colon cancer	3.98e-05	0.000213	CbGpPWpGaD
Metformin—NDUFA2—Metabolism—AKT1—colon cancer	3.98e-05	0.000213	CbGpPWpGaD
Metformin—NDUFB8—Metabolism—AKT1—colon cancer	3.98e-05	0.000213	CbGpPWpGaD
Metformin—NDUFS6—Metabolism—AKT1—colon cancer	3.98e-05	0.000213	CbGpPWpGaD
Metformin—NDUFS1—Metabolism—AKT1—colon cancer	3.98e-05	0.000213	CbGpPWpGaD
Metformin—NDUFC1—Metabolism—AKT1—colon cancer	3.98e-05	0.000213	CbGpPWpGaD
Metformin—NDUFB6—Metabolism—AKT1—colon cancer	3.98e-05	0.000213	CbGpPWpGaD
Metformin—NDUFB4—Metabolism—AKT1—colon cancer	3.98e-05	0.000213	CbGpPWpGaD
Metformin—NDUFA10—Metabolism—AKT1—colon cancer	3.98e-05	0.000213	CbGpPWpGaD
Metformin—NDUFAB1—Metabolism—AKT1—colon cancer	3.98e-05	0.000213	CbGpPWpGaD
Metformin—ND2—Metabolism—AKT1—colon cancer	3.98e-05	0.000213	CbGpPWpGaD
Metformin—NDUFB10—Metabolism—AKT1—colon cancer	3.98e-05	0.000213	CbGpPWpGaD
Metformin—NDUFV2—Metabolism—AKT1—colon cancer	3.98e-05	0.000213	CbGpPWpGaD
Metformin—NDUFA3—Metabolism—AKT1—colon cancer	3.98e-05	0.000213	CbGpPWpGaD
Metformin—NDUFA6—Metabolism—AKT1—colon cancer	3.98e-05	0.000213	CbGpPWpGaD
Metformin—NDUFA5—Metabolism—AKT1—colon cancer	3.98e-05	0.000213	CbGpPWpGaD
Metformin—NDUFV1—Metabolism—AKT1—colon cancer	3.98e-05	0.000213	CbGpPWpGaD
Metformin—NDUFB7—Metabolism—AKT1—colon cancer	3.98e-05	0.000213	CbGpPWpGaD
Metformin—NDUFB1—Metabolism—AKT1—colon cancer	3.98e-05	0.000213	CbGpPWpGaD
Metformin—ND3—Metabolism—AKT1—colon cancer	3.98e-05	0.000213	CbGpPWpGaD
Metformin—NDUFA7—Metabolism—AKT1—colon cancer	3.98e-05	0.000213	CbGpPWpGaD
Metformin—ND6—Metabolism—AKT1—colon cancer	3.98e-05	0.000213	CbGpPWpGaD
Metformin—NDUFS4—Metabolism—AKT1—colon cancer	3.98e-05	0.000213	CbGpPWpGaD
Metformin—ND4L—Metabolism—AKT1—colon cancer	3.98e-05	0.000213	CbGpPWpGaD
Metformin—ND5—Metabolism—AKT1—colon cancer	3.98e-05	0.000213	CbGpPWpGaD
Metformin—NDUFA4—Metabolism—AKT1—colon cancer	3.98e-05	0.000213	CbGpPWpGaD
Metformin—NDUFA9—Metabolism—AKT1—colon cancer	3.98e-05	0.000213	CbGpPWpGaD
Metformin—ND4—Metabolism—AKT1—colon cancer	3.98e-05	0.000213	CbGpPWpGaD
Metformin—NDUFS5—Metabolism—AKT1—colon cancer	3.98e-05	0.000213	CbGpPWpGaD
Metformin—NDUFB5—Metabolism—AKT1—colon cancer	3.98e-05	0.000213	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—APC—colon cancer	3.93e-05	0.000211	CbGpPWpGaD
Metformin—ND1—Metabolism—PTGS2—colon cancer	3.87e-05	0.000207	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—BRAF—colon cancer	3.69e-05	0.000198	CbGpPWpGaD
Metformin—NDUFC2—Metabolism—PIK3CA—colon cancer	3.69e-05	0.000198	CbGpPWpGaD
Metformin—NDUFS3—Metabolism—PIK3CA—colon cancer	3.69e-05	0.000198	CbGpPWpGaD
Metformin—NDUFS7—Metabolism—PIK3CA—colon cancer	3.69e-05	0.000198	CbGpPWpGaD
Metformin—NDUFV3—Metabolism—AKT1—colon cancer	3.55e-05	0.00019	CbGpPWpGaD
Metformin—NDUFS2—Metabolism—PIK3CA—colon cancer	3.47e-05	0.000186	CbGpPWpGaD
Metformin—SLC22A2—Transmission across Chemical Synapses—HRAS—colon cancer	3.33e-05	0.000179	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—ABCB1—colon cancer	3.29e-05	0.000177	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—TYMS—colon cancer	3.23e-05	0.000173	CbGpPWpGaD
Metformin—ND1—Metabolism—EP300—colon cancer	3.21e-05	0.000172	CbGpPWpGaD
Metformin—SLC22A1—Transmission across Chemical Synapses—HRAS—colon cancer	3.11e-05	0.000167	CbGpPWpGaD
Metformin—NDUFS7—Metabolism—AKT1—colon cancer	3.01e-05	0.000162	CbGpPWpGaD
Metformin—NDUFS3—Metabolism—AKT1—colon cancer	3.01e-05	0.000162	CbGpPWpGaD
Metformin—NDUFC2—Metabolism—AKT1—colon cancer	3.01e-05	0.000162	CbGpPWpGaD
Metformin—NDUFS2—Metabolism—AKT1—colon cancer	2.83e-05	0.000152	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CASP3—colon cancer	2.77e-05	0.000149	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CCND1—colon cancer	2.7e-05	0.000145	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CTNNB1—colon cancer	2.67e-05	0.000143	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CDKN1A—colon cancer	2.61e-05	0.00014	CbGpPWpGaD
Metformin—SLC22A2—Neuronal System—HRAS—colon cancer	2.55e-05	0.000137	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—EP300—colon cancer	2.48e-05	0.000133	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—SRC—colon cancer	2.41e-05	0.000129	CbGpPWpGaD
Metformin—SLC22A1—Neuronal System—HRAS—colon cancer	2.38e-05	0.000128	CbGpPWpGaD
Metformin—ND1—Metabolism—PIK3CA—colon cancer	2.38e-05	0.000128	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—VEGFA—colon cancer	2.35e-05	0.000126	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—NRAS—colon cancer	2.32e-05	0.000125	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PPARG—colon cancer	2.29e-05	0.000123	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—MYC—colon cancer	2.16e-05	0.000116	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—TGFB1—colon cancer	2.16e-05	0.000116	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—EGFR—colon cancer	2.11e-05	0.000113	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—ABCB1—colon cancer	2.06e-05	0.000111	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—TYMS—colon cancer	2.03e-05	0.000109	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—KRAS—colon cancer	2e-05	0.000107	CbGpPWpGaD
Metformin—ND1—Metabolism—AKT1—colon cancer	1.94e-05	0.000104	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—ABCB1—colon cancer	1.92e-05	0.000103	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—TYMS—colon cancer	1.89e-05	0.000101	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—PIK3CA—colon cancer	1.84e-05	9.85e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PTGS2—colon cancer	1.8e-05	9.66e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—TP53—colon cancer	1.78e-05	9.53e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—HRAS—colon cancer	1.7e-05	9.11e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—AKT1—colon cancer	1.5e-05	8.04e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—EP300—colon cancer	1.5e-05	8.04e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PPARG—colon cancer	1.44e-05	7.7e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PPARG—colon cancer	1.34e-05	7.18e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PTGS2—colon cancer	1.13e-05	6.06e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PIK3CA—colon cancer	1.11e-05	5.94e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PTGS2—colon cancer	1.05e-05	5.65e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—EP300—colon cancer	9.39e-06	5.04e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—AKT1—colon cancer	9.05e-06	4.86e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—EP300—colon cancer	8.76e-06	4.7e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PIK3CA—colon cancer	6.95e-06	3.73e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PIK3CA—colon cancer	6.48e-06	3.48e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—AKT1—colon cancer	5.68e-06	3.05e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—AKT1—colon cancer	5.29e-06	2.84e-05	CbGpPWpGaD
